Joe Armstrong

Dr. Armstrong joined Shuttle Pharma in 2020 as a Scientific Advisor with over 30 years of pharmaceutical industry experience in all drug discovery and development processes, project management, IND and NDA filings to the FDA. He received his PhD in organic chemistry from the University of Colorado. He has served as the Executive Vice President and Global Head of Research and Development for TCG GreenChem Inc. since 2017. From 1990-2017, in his positions as Senior Scientist-Director of Process Research, Director of Formulation and Executive Director Process R&D, at Merck & Co, Inc., he led the team that filed the drug Januvia for the treatment of type II diabetes, pioneered the use of novel catalytic asymmetric hydrogenation technologies for Januvia and led the Preclinical Development Lead for the integration of Merck and Schering Plough. He has over 40 peer-reviewed publications, 12 patents and frequent presentations at Pharma industry conferences.